Categories: Tech

cBrain appoints new CFO

Company Announcement no. 07/2025

cBrain appoints new CFO

Copenhagen, June 11, 2025

cBrain (NASDAQ: CBRAIN) is happy to announce that Lars Møller Christiansen has accepted the role as new CFO starting August 1st, 2025.

Lars Møller Christiansen comes from a position as Deputy Director at the Environmental Protection Agency (EPA), now known as the Agency for Green Land Use Planning and Aquatic Environment. Lars was responsible for financial management and digitization at the Danish EPA.

cBrain’s current CFO, Ejvind Jørgensen, wishes to step down after nine years in the role. Following a transition period, Ejvind will take up other responsibilities, still being part of the cBrain journey.

Lars is known as a digital front runner, and he brings in-depth knowledge of eGovernment. During his career in Danish government for more than 24 years, Lars has engaged in positions within financial management as well as led projects from ministerial digitization to digitizing environment and climate processes. In parallel with his role as the new CFO, Lars thereby brings solid experience, supporting cBrain’s international growth plan and leveraging Danish government expertise globally.

“Digital decision-making processes are crucial for the speed of the green transition. I am very much looking forward to applying my experience in an innovative tech company like cBrain, which has clear ambitions to make a difference for the climate and environment, both in Denmark and globally,” says Lars.

Best regards

Per Tejs Knudsen, CEO

Inquiries regarding this Company Announcement may be directed to 

Ejvind Jørgensen, CFO & Head of Investor Relations, cBrain A/S, ir@cbrain.com, +45 2594 4973

GlobeNews Wire

Published by
GlobeNews Wire

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

3 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

1 week ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago